SHELDON KAPLAN to Bacterial Vaccines
This is a "connection" page, showing publications SHELDON KAPLAN has written about Bacterial Vaccines.
Connection Strength
0.368
-
Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children with sickle hemoglobinopathy or malignancies, and after systemic Haemophilus influenzae type b infection. J Pediatr. 1992 Mar; 120(3):367-70.
Score: 0.095
-
Haemophilus influenzae type B conjugate vaccines. Pediatr Ann. 1990 Dec; 19(12):712-3, 716-8.
Score: 0.087
-
Immunogenicity of the Haemophilus influenzae type b capsular polysaccharide conjugate vaccine in children after systemic Haemophilus influenzae type b infections. J Pediatr. 1988 Aug; 113(2):272-7.
Score: 0.074
-
Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine. J Infect Dis. 2007 May 15; 195(10):1472-9.
Score: 0.067
-
New aspects of prevention and therapy of meningitis. Infect Dis Clin North Am. 1992 Mar; 6(1):197-214.
Score: 0.024
-
Immunogenicity of four Haemophilus influenzae type b conjugate vaccines in 17- to 19-month-old children. J Pediatr. 1991 Mar; 118(3):364-71.
Score: 0.022